company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,705344.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,438208.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1143552.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1143552.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3222.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,266.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2956.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1146508.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1146508.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1146508.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1146508.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16400000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16400000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17069849.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:11:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1792617.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,640236.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2432853.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2432853.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10580.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,80.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2443353.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2443353.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2443353.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2443353.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17107036.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 12:09:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1604407.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,632952.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2237359.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2237359.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8358.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,130.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6533877.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6542105.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8779464.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8779464.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8779464.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8779464.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18025851.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 14:02:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,567417.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1009213.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1576630.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1576630.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2069.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1243642.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1241573.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2818203.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2818203.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2818203.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2818203.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28284445.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 11:02:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6250.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6250.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6250.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1371949.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1404150.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2776099.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2769849.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2311.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,274410.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,276721.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2493128.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2493128.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-82500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2575628.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2575628.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28600000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28600000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28679942.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:01:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,960721.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3602082.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4562803.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4550303.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2174.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,362190.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,364364.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4185939.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4185939.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4185939.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4185939.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26013838.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1536201.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1536201.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1523701.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3553.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1315728.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1312175.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2835876.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2835876.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2835876.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2835876.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31126685.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 17:01:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,727164.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1551629.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2278793.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2266293.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3634.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-233226.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-229592.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2495885.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2495885.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2495885.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2495885.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31260070.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:01:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,677928.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2135385.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2813313.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2800813.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7911.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,208934.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,216845.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2583968.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2583968.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2583968.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2583968.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36477907.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 06:03:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2885126.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2357323.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5242449.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5229949.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6845.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1545788.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1552633.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3677316.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3677316.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3677316.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3677316.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34100000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34100000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33983590.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1311800.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2786822.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4098622.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4086122.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4277.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-126478.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-122201.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4208323.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4208323.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4208323.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-29695.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4178628.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37072509.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:00:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1732592.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4736950.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6469542.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6457042.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3172.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-139389.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-136217.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6593259.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6593259.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6593259.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-175638.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6417621.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37800000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37800000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37090989.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:09:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1536231.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4419703.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5955934.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5943434.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1114.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-251610.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-250496.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6193930.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6193930.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6193930.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-121851.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6072079.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37106190.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 08:30:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2896773.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4653002.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7549775.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7537275.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-12287.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-8563.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,637.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4361.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7532914.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7532914.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7532914.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-192684.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7340230.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38100000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38100000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38294259.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2658772.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7828985.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10487757.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10475257.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3495.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3495.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10471762.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3495.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10468267.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10471762.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-229579.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10242183.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44950267.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 09:01:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21429.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21429.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21429.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21429.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7505.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7505.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28934.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-8954125.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8940201.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8932696.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-241176.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8691520.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51100000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51100000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51917528.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21429.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21429.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21429.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3299043.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6219598.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9518641.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9497212.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-5547.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5547.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9491665.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9491665.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9491665.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-211635.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9280030.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51600000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51600000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51969836.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:07:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1873270.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3920438.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5793708.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5793708.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44477.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,44477.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5749231.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5749231.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1842189.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7591420.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-307837.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7283583.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51981340.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 09:05:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2666196.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3113239.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5779435.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5779435.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12422.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12422.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5767013.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,12422.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5767013.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1946666.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7713679.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-358252.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7355427.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51989986.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 16:06:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1646625.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3653743.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5300368.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5300368.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1299.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1299.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5301667.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5301667.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-2276189.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7577856.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-421095.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7156761.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51100000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51100000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51998306.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 08:06:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2869794.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4424266.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7294060.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7294060.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-8535.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12788.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4253.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7289807.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-12422.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7289807.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-3541155.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10830962.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-616491.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10214471.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51600000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51600000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51992048.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2110896.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4311527.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6422423.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6422423.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-352520.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10154.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-342366.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6764789.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6764789.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6764789.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6764789.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52016034.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 17:20:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1563013.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2804948.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4367961.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4367961.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-690834.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6555.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-684279.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5052240.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5052240.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5052240.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5052240.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52016432.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 06:11:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1555527.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1788224.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3343751.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3343751.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-648378.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-648378.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3992129.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3992129.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3992129.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3992129.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57000000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53842234.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 06:11:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1306631.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1641588.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2948219.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2948219.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-406253.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-406252.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3354471.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3354471.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3354471.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3354471.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53773145.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1362668.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1640337.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3003005.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3003005.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1098795.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1098795.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1904210.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1904210.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1904210.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1904210.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63500000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57240081.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 06:14:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1340528.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3349742.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4690270.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4690270.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2081717.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2081717.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2608553.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2608553.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2608553.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2608553.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60623778.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 18:47:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1113312.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1992825.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3106137.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3106137.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1146772.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1146772.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4252909.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4252909.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4252909.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4252909.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68232409.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 06:13:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1438959.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3437828.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4876787.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4876787.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38249486.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38249486.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43126273.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43126273.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43126273.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43126273.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65700000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65700000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65297348.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1530357.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2044476.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3574833.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3574833.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25614305.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25614305.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22039472.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22039472.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22039472.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22039472.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,81600000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81600000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82943340.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:23:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1016854.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2114783.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3131637.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3131637.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7751838.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7751838.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4620201.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4620201.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4620201.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4620201.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86300054.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92999810.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92400000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,756104.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1184194.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1940298.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1940298.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3190.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7744708.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7741518.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5801220.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5801220.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5801220.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5801220.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,96930270.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115346118.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96700000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:32:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1051685.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1485547.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2537232.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2537232.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1810.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4064149.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4062339.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1525107.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1525107.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1525107.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1525107.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73358034.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91091879.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1112000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1564000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2676000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2676000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3160000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3136000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5812000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5812000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5812000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5812000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111104000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,111104000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,116200000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:07:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1444654.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2136834.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3581488.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3581488.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21085.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3981169.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4002254.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,420766.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,420766.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,420766.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,420766.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115031289.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118770096.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1744694.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3427985.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5172679.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5172679.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8025.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2054561.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2046536.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7219215.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7219215.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7219215.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7219215.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142207862.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142207862.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,144400000.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:32:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1652652.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5493181.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7145833.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7145833.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23890.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6102392.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6126282.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1019551.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1019551.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1019551.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1019551.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,130601500.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131135178.0
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Ampio Pharmaceuticals Inc,AMPE,,0001411906,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,136300000.0
